BackOur services

Our reputation as a leading global corporate finance house, is built on our knowledge, sector focus and bespoke service offering.

View all
BackOur sectors

Helping clients achieve their goals through our sector insight and extensive market knowledge lies at the heart of our ethos.

View all

Healthcare

Maximising opportunities

We work closely with entrepreneurs and investors at the forefront of the global healthcare revolution. Our in-depth sector knowledge, combined with our technical capability, enables us to help corporates and investors capitalise on the enormous opportunities across the sector as they seek to consolidate and grow their market positions.

The ageing population, technological change, and increased demand for healthcare products and services, all create great opportunities in the health and social care, medical devices, life sciences, bioscience and pharmaceutical markets. Our job is to help our clients maximise those opportunities.

< >

Our latest transactions

See our transactions

Clearwater has been very professional in leading the process involving candidates from all over the world.

Luc Bertholat, Partner, Naxicap Partners

Our Healthcare Team

The team were quickly able to identify the right partner for us and used their excellent relationship with the buyer to help negotiate a transaction that met our objectives.
Dan Smart, CEO, Proclinical

With in-depth knowledge and technical capability, our healthcare team has a great track record of delivering tailored solutions.

See our team

Over 60

deals advised upon

in the last 5 years

€9.2bn

in deal value

over the last 5 years

Over 45%

deals involving PE

in the last 5 years

Insights

  • Spotlight on Sweden

    Sweden saw strong levels of dealflow in Q3, but limited access for cross-border buyers and scarcer debt financing continue to pose challenges, says Clearwater International’s Managing Partner Tomas Almgren.

    Read more

  • European overview

    This report identifies key themes driving European Private Equity (PE) deals’ EV/EBITDA multiples on a quarterly basis. The objective is to assist PE investors in understanding drivers behind value trends across regions and sectors, leading to good investment opportunities.

    Read more
  • conference-meeting

    Multiples Heatmap Analysis Q3 2020

    In-depth analysis of the acquisition multiples paid for European private equity transactions.

    Read more
See more Insights
Scroll to Top